Chronic kidney disease is the leading cause of death in senior cats and requires long-term management to maintain quality of life.
Chronic kidney disease causes progressive welfare impacts through uremic toxin accumulation, nausea, reduced appetite, hypertension, anemia, and dehydration that compound over the disease course. Early stage CKD causes few visible welfare impacts, making early detection through SDMA testing important for initiating management before the cat experiences significant ill health. The welfare trajectory in managed CKD can be substantially better than unmanaged disease: phosphorus restriction slows progression, antihypertensive medication prevents the acute welfare emergency of retinal detachment and sudden blindness, and home fluid therapy addresses the chronic dehydration that worsens uremic symptoms. The home fluid therapy skill, while initially daunting for owners, enables cats to remain at home during treatment rather than requiring repeated stressful clinic visits, improving quality of life substantially. End-stage CKD causes profound suffering from uremia, and timely euthanasia before uremic crises represents a welfare-positive owner decision.